Zuellig buys Symbion Pharmacy business in Australia
The HK-based business group shells out $438 million to add the Symbion Pharmacy business in Australia, owned by Primary Health Care, to its own stable of pharmaceuticals companies.
Hong Kong-headquartered Zuellig Group, a privately owned conglomerate, will acquire the Symbion Pharmacy business from AustraliaÆs Primary Healthcare for A$505 million $438 million.
On behalf of Primary Health Care, Caliburn Partnership ran an auction first for SymbionÆs consumer business and more recently for the pharmacy business. The consumer business realised A$560 million.
The background to the disposals lies in PrimaryÆs A$2.65 billion takeover of Symbion earlier this year. Primary Health Care and Symbion started dialogue in September 2006 when...
To continue reading, please login or register for free